Over but not gone: lingering epigenetic effects of COVID-19
Trends in Immunology · 2023
DOI: 10.1016/j.it.2023.08.012 ↗Kurz gefasst
Fachartikel in der Zeitschrift Trends in Immunology, 2023. Verfasst von Brandon T Tran und 2 weiteren Autor:innen. Beteiligte Einrichtung: Program in Cancer and Cell Biology, Graduate School of Biomedical Sciences, Baylor College of Medicine, Houston, TX, USA. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NHLBI NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Program in Cancer and Cell Biology, Graduate School of Biomedical Sciences, Baylor College of Medicine, Houston, TX, USA.
- Program in Immunology and Microbiology, Graduate School of Biomedical Sciences, Baylor College of Medicine, Houston, TX, USA.
- Program in Cancer and Cell Biology, Graduate School of Biomedical Sciences, Baylor College of Medicine, Houston, TX, USA; Program in Immunology and Microbiology, Graduate School of Biomedical Sciences, Baylor College of…
Förderung
- NIAID NIH HHS
- NHLBI NIH HHS
- NCI NIH HHS
- National Heart Lung and Blood Institute
- National Cancer Institute
- National Institutes of Health
Zitieren
APA
Tran, B. T., Cao, R., & King, K. Y. (2023). Over but not gone: lingering epigenetic effects of COVID-19. Trends in Immunology. https://doi.org/10.1016/j.it.2023.08.012
Vancouver
Tran BT, Cao R, King KY. Over but not gone: lingering epigenetic effects of COVID-19. Trends in Immunology. 2023. doi:10.1016/j.it.2023.08.012
BibTeX
@article{Tran2023,
author = {Tran, Brandon T and Cao, Ruoqiong and King, Katherine Y},
title = {Over but not gone: lingering epigenetic effects of COVID-19},
journal = {Trends in Immunology},
year = {2023},
doi = {10.1016/j.it.2023.08.012}
}
EUVIMED